These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 20840386)
1. The effects of L-659,066, a peripheral α2-adrenoceptor antagonist, and verapamil on the cardiovascular influences of dexmedetomidine in conscious sheep. Raekallio MR; Honkavaara JM; Vainio OM J Vet Pharmacol Ther; 2010 Oct; 33(5):434-8. PubMed ID: 20840386 [TBL] [Abstract][Full Text] [Related]
2. A novel alpha 2-adrenoceptor antagonist attenuates the early, but preserves the late cardiovascular effects of intravenous dexmedetomidine in conscious dogs. Pagel PS; Proctor LT; Devcic A; Hettrick DA; Kersten JR; Tessmer JP; Farber NE; Schmeling WT; Warltier DC J Cardiothorac Vasc Anesth; 1998 Aug; 12(4):429-34. PubMed ID: 9713732 [TBL] [Abstract][Full Text] [Related]
3. The effects of increasing doses of MK-467, a peripheral alpha(2)-adrenergic receptor antagonist, on the cardiopulmonary effects of intravenous dexmedetomidine in conscious dogs. Honkavaara JM; Restitutti F; Raekallio MR; Kuusela EK; Vainio OM J Vet Pharmacol Ther; 2011 Aug; 34(4):332-7. PubMed ID: 20969603 [TBL] [Abstract][Full Text] [Related]
4. Cardiopulmonary effects of dexmedetomidine, with and without vatinoxan, in isoflurane-anesthetized cats. Jaeger AT; Pypendop BH; Ahokoivu H; Honkavaara J Vet Anaesth Analg; 2019 Nov; 46(6):753-764. PubMed ID: 31416697 [TBL] [Abstract][Full Text] [Related]
5. Hemodynamic effects of dexmedetomidine, with and without MK-467, following intramuscular administration in cats anesthetized with isoflurane. Siao KT; Pypendop BH; Honkavaara J; Ilkiw JE Vet Anaesth Analg; 2017 Sep; 44(5):1101-1115. PubMed ID: 29056418 [TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and sedation reversal effects of intramuscular administration of atipamezole in dogs treated with medetomidine hydrochloride with or without the peripheral α Turunen H; Raekallio MR; Honkavaara JM; Restitutti F; Kallio-Kujala IJ; Adam M; Nevanperä K; Scheinin M; Männikkö SK; Hautajärvi HJ; Larenza Menzies P; Vainio OM Am J Vet Res; 2019 Oct; 80(10):912-922. PubMed ID: 31556714 [TBL] [Abstract][Full Text] [Related]
7. The cardiopulmonary effects of a peripheral alpha-2-adrenoceptor antagonist, MK-467, in dogs sedated with a combination of medetomidine and butorphanol. Salla K; Restitutti F; Vainionpää M; Junnila J; Honkavaara J; Kuusela E; Raekallio M; Vainio O Vet Anaesth Analg; 2014 Nov; 41(6):567-74. PubMed ID: 24674053 [TBL] [Abstract][Full Text] [Related]
8. The effects of L-659,066, a peripheral alpha2-adrenoceptor antagonist, on dexmedetomidine-induced sedation and bradycardia in dogs. Honkavaara JM; Raekallio MR; Kuusela EK; Hyvärinen EA; Vainio OM Vet Anaesth Analg; 2008 Sep; 35(5):409-13. PubMed ID: 18466161 [TBL] [Abstract][Full Text] [Related]
9. The impact of MK-467 on sedation, heart rate and arterial blood pressure after intramuscular coadministration with dexmedetomidine in conscious cats. Honkavaara J; Pypendop B; Ilkiw J Vet Anaesth Analg; 2017 Jul; 44(4):811-822. PubMed ID: 28734853 [TBL] [Abstract][Full Text] [Related]
10. Cardiopulmonary effects of dexmedetomidine in sevoflurane-anesthetized sheep with and without nitric oxide inhalation. Kästner SB; Kull S; Kutter AP; Boller J; Bettschart-Wolfensberger R; Huhtinen MK Am J Vet Res; 2005 Sep; 66(9):1496-502. PubMed ID: 16261821 [TBL] [Abstract][Full Text] [Related]
11. Cardiopulmonary effects of vatinoxan in sevoflurane-anaesthetised sheep receiving dexmedetomidine. Adam M; Huuskonen V; Raekallio MR; Casoni D; Mykkänen AK; Lappalainen AK; Kajula M; Kallio-Kujala IJ; Vainio OM Vet J; 2018 Aug; 238():63-69. PubMed ID: 30103917 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of dexmedetomidine, with or without MK-467, following intravenous administration in cats. Pypendop BH; Honkavaara J; Ilkiw JE Vet Anaesth Analg; 2017 Jan; 44(1):52-62. PubMed ID: 27377604 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of dexmedetomidine sedation in children. Wong J; Steil GM; Curtis M; Papas A; Zurakowski D; Mason KP Anesth Analg; 2012 Jan; 114(1):193-9. PubMed ID: 21965374 [TBL] [Abstract][Full Text] [Related]
14. Effects of different doses of L-659'066 on the bispectral index and clinical sedation in dogs treated with dexmedetomidine. Restitutti F; Honkavaara JM; Raekallio MR; Kuusela EK; Vainio OM Vet Anaesth Analg; 2011 Sep; 38(5):415-22. PubMed ID: 21831046 [TBL] [Abstract][Full Text] [Related]
15. Effect of MK-467 on organ blood flow parameters detected by contrast-enhanced ultrasound in dogs treated with dexmedetomidine. Restitutti F; Laitinen MR; Raekallio MR; Vainionpää M; O'Brien RT; Kuusela E; Vainio OM Vet Anaesth Analg; 2013 Nov; 40(6):e48-56. PubMed ID: 23802592 [TBL] [Abstract][Full Text] [Related]
16. Plasma concentration and cardiovascular effects of intramuscular medetomidine combined with three doses of the peripheral alpha Restitutti F; Kaartinen MJ; Raekallio MR; Wejberg O; Mikkola E; Del Castillo JRE; Scheinin M; Vainio OM Vet Anaesth Analg; 2017 May; 44(3):417-426. PubMed ID: 28552594 [TBL] [Abstract][Full Text] [Related]
17. Dexmedetomidine decreases the oral mucosal blood flow. Kawaai H; Yoshida K; Tanaka E; Togami K; Tada H; Ganzberg S; Yamazaki S Br J Oral Maxillofac Surg; 2013 Dec; 51(8):928-31. PubMed ID: 23958351 [TBL] [Abstract][Full Text] [Related]
18. The sedative effects and the attenuation of cardiovascular and arousal responses during anesthesia induction and intubation in pediatric patients: a randomized comparison between two different doses of preoperative intranasal dexmedetomidine. Wang SS; Zhang MZ; Sun Y; Wu C; Xu WY; Bai J; Cai MH; Lin L Paediatr Anaesth; 2014 Mar; 24(3):275-81. PubMed ID: 24224515 [TBL] [Abstract][Full Text] [Related]
19. Effects of the peripherally acting α Adam M; Raekallio MR; Salla KM; Honkavaara JM; Männikkö S; Scheinin M; Kajula M; Mölsä SH; Vainio OM Am J Vet Res; 2018 Sep; 79(9):921-932. PubMed ID: 30153057 [TBL] [Abstract][Full Text] [Related]
20. Cardiopulmonary effects and pharmacokinetics of i.v. dexmedetomidine in ponies. Bettschart-Wolfensberger R; Freeman SL; Bowen IM; Aliabadi FS; Weller R; Huhtinen M; Clarke KW Equine Vet J; 2005 Jan; 37(1):60-4. PubMed ID: 15651736 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]